Merocon 500 mg/vial (IV Injection or Infusion)
500 mg vial: ৳ 750.00
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Beacon pharmaceuticals plc |
Also available as |
Indications
- Treats pneumonia and nosocomial pneumonia
- Treats urinary tract infections
- Treats intra-abdominal infections
- Treats gynaecological infections
- Treats skin and skin structure infections
- Treats meningitis
- Treats septicaemia
- Treats pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
- Exerts bactericidal action
- Interferes with bacterial cell wall synthesis
- Potent bactericidal activity against a broad spectrum of bacteria
- Penetrates bacterial cell walls
- High stability to all serine beta-lactamases
- Marked affinity for the Penicillin Binding Proteins (PBPs)
Dosage
- Dependent on type and severity of infection
- Varied dosage for different types of infections
- Recommended daily dosage for adults
- Recommended daily dosage for children
- Intravenous administration every 8 hours for adults
- Intravenous administration every 8 hours for children
Administration
- Administered by intravenous infusion over approximately 15-30 minutes
- Administered as intravenous bolus over approximately 3-5 minutes
Interaction
- Probenecid competes with Merocon for active tubular secretion
- Inhibits renal excretion of Merocon
- May reduce serum valproic acid levels
Contraindications
- Contraindicated in patients with demonstrated hypersensitivity to the product
Side Effects
- Inflammation at the site of injection
- Thrombophlebitis
- Skin reactions like rash, pruritus, urticaria
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
Pregnancy & Lactation
- Pregnancy Category B
- Caution should be exercised when administered to a nursing woman
Precautions & Warnings
- If allergic reaction occurs, discontinue the drug
- Careful monitoring of transaminase and bilirubin levels in patients with hepatic disease
Use in Special Populations
- Dosage reduction in patients with renal impairment
- No dosage adjustments necessary with impairment of liver function
- Administration after dialysis for hemodialysis patients
- Efficacy and tolerability in infants under 3 months not established
Overdose Effects
- Accidental overdose could occur, particularly in patients with renal impairment
- Symptomatic treatment for overdose
Therapeutic Class
- Belongs to the class of other beta-lactam antibiotics
Reconstitution
- Preparation of solution for intravenous bolus administration
- Preparation of solution for intravenous infusion administration
- Compatibility with various infusion fluids
- Recommended use of freshly reconstituted solution
Storage Conditions
- Store in a cool, dry place below 30°C
- Keep away from light and moisture
- Keep out of the reach of children
Related Brands
- Merocon 1 gm/vial (IV Injection or Infusion) - beacon-pharmaceuticals-plc
- Rosebac 500 mg/vial (IV Injection or Infusion) - concord-pharmaceuticals-ltd
- Rosebac 1 gm/vial (IV Injection or Infusion) - concord-pharmaceuticals-ltd
- Veronem 500 mg/vial (IV Injection or Infusion) - veritas-pharmaceuticals-ltd
- Veronem 1 gm/vial (IV Injection or Infusion) - veritas-pharmaceuticals-ltd